DIAPH1

Protein diaphanous homolog 1 · O60610 · DIAPH1 on Sugi Atlas →

0 patent compounds predicted against DIAPH1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to DIAPH1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Treatment With HMG-COA Reductase Inhibitor of Growth and Bone Abnormalities in Children With Noonan Syndrome PHASE3COMPLETED
Antioxidant Therapy With N-acetylcysteine for Learning and Motor Behavior in Children With Neurofibromatosis Type 1 PHASE2COMPLETED
Antioxidant Therapy With N-acetylcysteine for Children With Neurofibromatosis Type 1 PHASE2COMPLETED
Combination Therapy (Mirdametinib and Sirolimus) for RAS Mutated Relapsed Refractory Multiple Myeloma PHASE1/PHASE2SUSPENDED
Study of ISM6331 in Participants With Advanced/Metastatic Malignant Mesothelioma or Other Solid Tumors PHASE1RECRUITING
Interleukin-2 Treatment for Wiskott-Aldrich Syndrome PHASE1COMPLETED
Evaluation of Formin Gene Status and Expression in Myeloproliferative and Myelodysplastic Disorders nanCOMPLETED
Podocyts Integrity in Glomerular Diseases nanUNKNOWN
Genetic Study of Patients and Families With Diaphyseal Medullary Stenosis With Malignant Fibrous Histiocytoma of the Bone nanCOMPLETED
Genetic Identification (ID) of Segmental Dysplastic Nevi nanWITHDRAWN
Gene Mutations and Rescue in Human Congenital Diaphragmatic Hernia nanUNKNOWN
Diaphragmatic Hernia Research & Exploration, Advancing Molecular Science nanRECRUITING
Investigating the Genetic Basis of Pseudoexfoliation Syndrome, Angle-closure Glaucoma and Primary Open-angle Glaucoma nanRECRUITING
Study of Skeletal Disorders and Short Stature nanCOMPLETED
Genetic Mechanisms and Additional Risk Factors Underlying Hip Dysplasia nanCOMPLETED
The Activation of Hippo Pathway in Nasal Polyps nanUNKNOWN
Implication of Long Non-coding RNA CCDC144NL-AS1/Micro RNA-143-3p Axis Expression Level as Novel Signature in Colorectal Cancer nanCOMPLETED
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve nanUNKNOWN
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients nanRECRUITING
Molecular Characterization of Spinal Tissue nanENROLLING_BY_INVITATION
Observational Cohort Study of Dysferlinopathy in China nanCOMPLETED
Development of Primary Cultures of Diaphragmatic Myoblasts for Basic Research Purposes nanNOT_YET_RECRUITING
Institution of an Italian Multicenter Database of Patients With Multiple Endocrine Neoplasia Type 1 (MENNET1 Database) nanNOT_YET_RECRUITING
A Retrospective Study to Determine the Incidence of NTRK Fusions. NTRK Study nanCOMPLETED
Study of Blood Samples From Patients With Ewing Sarcoma and Their Relatives nanCOMPLETED
Familial Intracranial Aneurysm Study II nanCOMPLETED
Clinical Outcome Study for Dysferlinopathy nanUNKNOWN
Markers and Mechanisms of Macrovascular Disease in IDDM nanCOMPLETED
B3 for NMD: Bench to Bedside and Back nanENROLLING_BY_INVITATION
Aberrant Gene Expression Prostate Carcinoma nanACTIVE_NOT_RECRUITING

Related proteins — ESM-2 sequence neighbours (a DIAPH1 binder may also engage these)

ProteinNameSimilarity
O08808 1.000 O08808 →
F1M775 0.998 F1M775 →
A2APV2 0.988 A2APV2 →
FMNL1 Formin-like protein 1 0.987 landscape →
F1LVW7 0.987 F1LVW7 →
Q9JL26 0.986 Q9JL26 →
Q6NTV6 0.985 Q6NTV6 →
Q6NXC0 0.984 Q6NXC0 →
A0A3Q1LSX9 0.984 A0A3Q1LSX9 →
Q96PY5 0.984 Q96PY5 →
Q9Z207 0.984 Q9Z207 →
Q6ZPF4 0.982 Q6ZPF4 →
Q86T65 0.982 Q86T65 →
Q8BMI3 0.981 Q8BMI3 →
Q8IVF7 0.981 Q8IVF7 →
Q0IHV1 0.981 Q0IHV1 →
Q6P2K6 0.981 Q6P2K6 →
PPP4R3A Serine/threonine-protein phosphatase 4 regulatory subunit 3A 0.980 landscape →
Q0GNC1 0.979 Q0GNC1 →
Q6INN7 0.979 Q6INN7 →
Q9UJY5 0.978 Q9UJY5 →
Q9C6S1 0.978 Q9C6S1 →
P51432 0.978 P51432 →
Q5SP90 0.978 Q5SP90 →
Q9Y4D1 0.978 Q9Y4D1 →
Q99MP8 0.977 Q99MP8 →
B0DOB5 0.977 B0DOB5 →
Q41583 0.977 Q41583 →
Q9NSV4 0.976 Q9NSV4 →
Q8BPM0 0.976 Q8BPM0 →